Literature DB >> 3127543

Aetiological agent of enterically transmitted non-A, non-B hepatitis.

D Bradley1, A Andjaparidze, E H Cook, K McCaustland, M Balayan, H Stetler, O Velazquez, B Robertson, C Humphrey, M Kane.   

Abstract

Virus-like particles (VLPs) with a mean diameter of 32 nm were recovered from the stools of three acute phase cases of enterically transmitted non-A, non-B hepatitis (ET-NANBH) occurring in the Soviet Union, North Africa and North America. VLPs from two of these cases were studied in detail and were shown to react specifically with antibody in acute phase sera obtained from other cases of ET-NANBH in Asia, the Soviet Union, North Africa and North America. Partially purified VLPs were found to sediment at 183S in sucrose gradients and to cross-react with antibody in acute phase sera from geographically isolated cases of ET-NANBH. The latter virus preparations were also used to document the seroconversion of experimentally ET-NANBH-infected cynomolgus macaques to 32 nm VLPs. Our findings indicate that one virus or class of viruses is responsible for the majority of ET-NANBH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127543     DOI: 10.1099/0022-1317-69-3-731

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.

Authors:  Y Zhang; P McAtee; P O Yarbough; A W Tam; T Fuerst
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 4.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

5.  Hepatitis E virus (HEV): strain variation in the nonstructural gene region encoding consensus motifs for an RNA-dependent RNA polymerase and an ATP/GTP binding site.

Authors:  K E Fry; A W Tam; M M Smith; J P Kim; K C Luk; L M Young; M Piatak; R A Feldman; K Y Yun; M A Purdy
Journal:  Virus Genes       Date:  1992-04       Impact factor: 2.332

6.  Virus-specific mRNA capping enzyme encoded by hepatitis E virus.

Authors:  J Magden; N Takeda; T Li; P Auvinen; T Ahola; T Miyamura; A Merits; L Kääriäinen
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions.

Authors:  S Yin; R H Purcell; S U Emerson
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

8.  Classification of medically important viruses II: RNA viruses.

Authors:  Pushker Raj
Journal:  Clin Microbiol Newsl       Date:  2002-11-14

Review 9.  Naturally occurring animal models of human hepatitis E virus infection.

Authors:  Danielle M Yugo; Caitlin M Cossaboom; Xiang-Jin Meng
Journal:  ILAR J       Date:  2014

10.  Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure.

Authors:  Tetsuo Yamashita; Yoshio Mori; Naoyuki Miyazaki; R Holland Cheng; Masato Yoshimura; Hideaki Unno; Ryoichi Shima; Kohji Moriishi; Tomitake Tsukihara; Tian Cheng Li; Naokazu Takeda; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.